Metagenomi Therapeutics, Inc.
MGX · XNASCIK 1785279fmd_1JKWDF0N1PAY4GYZ4JSTHRFB75Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2023 to Sep 30, 2026, 15 periods
Ratios computed from the standardized statements. Select a value to open its proof.
Loading